Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9850)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2017 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li CJ, Yang ZH, Shi XL, Liu DL. Effects of aspirin and enoxaparin in a rat model of liver fibrosis. World J Gastroenterol 2017; 23(35): 6412-6419 [PMID: 29085190 DOI: 10.3748/wjg.v23.i35.6412] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i35/6412.htm |
| Number | Citing Articles |
| 1 |
Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Nieß, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin, Jens Werner, Florian Kühn. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. Journal of Gastrointestinal Surgery 2022; 26(3): 671 doi: 10.1007/s11605-021-05188-7
|
| 2 |
Ru Huang, Juan Deng, Chang-Peng Zhu, Shu-Qing Liu, Ya-Lu Cui, Fei Chen, Xin Zhang, Xia Tao, Wei-Fen Xie. Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell. Biomedicine & Pharmacotherapy 2023; 160: 114396 doi: 10.1016/j.biopha.2023.114396
|
| 3 |
Niccolò Bitto, Eleonora Liguori, Vincenzo La Mura. Coagulation, Microenvironment and Liver Fibrosis. Cells 2018; 7(8): 85 doi: 10.3390/cells7080085
|
| 4 |
Harsha Kabra, Tanaya Walimbe, Kate Stuart, Camille Indey, Swati Jalgaonkar, Elvis Ikwa, Taylor Skurnac, Julia Chen, Andrew Woolley, Nicholas M. Snead, Nathan Bachtell, Diana J. Leeming, Morten Karsdal, Glenn Prestwich, Alyssa Panitch, John Paderi. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021; 269: 120538 doi: 10.1016/j.biomaterials.2020.120538
|
| 5 |
ShuTing Wu, XinXin Wang, WenBo Xing, FenYao Li, Ming Liang, KeShen Li, Yan He, JianMing Wang. An update on animal models of liver fibrosis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1160053
|
| 6 |
Peng Huang, Benson Kaluba, Xiao-lin Jiang, Shi Chang, Xiao-feng Tang, Lin-feng Mao, Zhi-peng Zhang, Fei-zhou Huang. Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/8071093
|
| 7 |
Thit Mynster Kronborg, Henriette Ytting, Lise Hobolth, Søren Møller, Nina Kimer. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.718896
|
| 8 |
Rui Zhang, Xiaoquan Huang, Yingyi Jiang, Jian Wang, Shiyao Chen, Alessandro Granito. Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8887574
|
| 9 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|
| 10 |
Niccolò Bitto, Gabriele Ghigliazza, Stanislao Lavorato, Camilla Caputo, Vincenzo La Mura. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis. Journal of Clinical Medicine 2023; 12(3): 934 doi: 10.3390/jcm12030934
|
| 11 |
Carlo Airola, Maria Pallozzi, Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani. Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications. Cells 2023; 12(13): 1712 doi: 10.3390/cells12131712
|
| 12 |
MARIA DE LOURDES PESSOLE BIONDO-SIMÕES, VICTOR CEZAR DE AZEVEDO PESSINI, CAROLINA AYUMI ICHI, ROGÉRIO RIBEIRO ROBES, SÉRGIO IOSHII. Acetylsalicylic acid (Aspirin®) and liver regeneration: experimental study in rats. Revista do Colégio Brasileiro de Cirurgiões 2021; 48 doi: 10.1590/0100-6991e-20213164
|
| 13 |
Ting Hong, Yazhong Wei, Xiaomei Xue, Yongyong Li, Haiqing Dong, Xiaoyu Guo, Xueyin Shi, Bin He. A Novel Anti‐Coagulative Nanocomplex in Delivering miRNA‐1 Inhibitor Against Microvascular Obstruction of Myocardial Infarction. Advanced Healthcare Materials 2020; 9(11) doi: 10.1002/adhm.201901783
|
| 14 |
Patrizia Ballerini, Annalisa Contursi, Annalisa Bruno, Matteo Mucci, Stefania Tacconelli, Paola Patrignani. Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.838079
|
| 15 |
Mohammad Reza Ghadir, Seyed Saeed Sarkeshikian, Ahmad Hormati, Faezeh Alemi, Pezhman Alavinejad, Maryam Jameshorani, Mansoureh Molaei, Mahdi Jahangiry. Efficacy of Atorvastatin Plus Aspirin in Comparison with Atorvastatin Alone on Liver Function and Degree of Fibrosis in Patients with Cryptogenic Cirrhosis: A Randomized Double-Blind Clinical Trial. Hepatitis Monthly 2019; 19(11) doi: 10.5812/hepatmon.92342
|
| 16 |
Omnyah A. El-Kharashi, Dalia Alaa El-Din Aly El-Waseef, Enas S. Nabih, Doaa I. Mohamed. Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats. Biomedicine & Pharmacotherapy 2018; 107: 665 doi: 10.1016/j.biopha.2018.08.032
|
| 17 |
Marie‐Astrid van Dievoet, Isabelle Leclercq, Cedric Hermans, Catherine Lambert, Yves Horsmans, Marc Jacquemin, Stéphane Eeckhoudt. Does haemophilia slow down the development of liver fibrosis?. Haemophilia 2019; 25(1) doi: 10.1111/hae.13630
|
| 18 |
David Niederseer, Bernhard Wernly, Elmar Aigner, Felix Stickel, Christian Datz. NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. Journal of Clinical Medicine 2021; 10(3): 467 doi: 10.3390/jcm10030467
|
| 19 |
Yimin Sun, Bingyan Liu, Jianping Xie, Xuefeng Jiang, Baolai Xiao, Xiaomiao Hu, Jinjian Xiang. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling. Molecular Medicine Reports 2022; 25(5) doi: 10.3892/mmr.2022.12697
|
| 20 |
Nesreen Ishak Mahmoud, Basim A.S. Messiha, Ibrahim G. Salehc, Ali A. Abo-Saif, Mohamed S. Abdel-Bakky. Interruption of platelets and thrombin function as a new approach against liver fibrosis induced experimentally in rats. Life Sciences 2019; 231: 116522 doi: 10.1016/j.lfs.2019.05.078
|
| 21 |
Hanna Oh, Hye Eun Park, Min Su Song, HaYoung Kim, Jea-Hyun Baek. The Therapeutic Potential of Anticoagulation in Organ Fibrosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.866746
|
| 22 |
Nicoleta State, Victor Stoica. Antithrombotic Drugs in Cirrhosis. Internal Medicine 2020; 17(6): 7 doi: 10.2478/inmed-2020-0138
|
| 23 |
Moying Li, Timo Itzel, Nathally Espinosa Montagut, Thomas Falconer, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias Philip Ebert, George Hripcsak, Andreas Teufel. Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 2023; 58(12): 1505 doi: 10.1080/00365521.2023.2239974
|
| 24 |
Pengyan Fa, Benjamin G. Ke, Abigail Dupre, Allan Tsung, Hongji Zhang. The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1292679
|
| 25 |
Thanita Thongtan, Anasua Deb, Wasawat Vutthikraivit, Passisd Laoveeravat, Thammasak Mingbunjerdsuk, Sameer Islam, Ebtesam Islam. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Indian Journal of Gastroenterology 2022; 41(2): 119 doi: 10.1007/s12664-021-01230-3
|
| 26 |
Kotaro Nishi, Hiroshi Yagi, Mana Ohtomo, Shogo Nagata, Daisuke Udagawa, Tomonori Tsuchida, Toshinori Morisaku, Yuko Kitagawa. A thioacetamide-induced liver fibrosis model for pre-clinical studies in microminipig. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42144-8
|
| 27 |
Orhan Fındık, Melda Yardımoglu Yılmaz, Yusufhan Yazır, Selenay Furat Rençber, Kübra Kavram Sarıhan, Atike Tekeli Kunt. Investigation of the protective effect of enoxaparin and ticagrelor pretreatment against ischemia-reperfusion injury in rat lung tissue. Revista da Associação Médica Brasileira 2019; 65(9): 1193 doi: 10.1590/1806-9282.65.9.1193
|
| 28 |
Wenxia Yi, Chunyan Zhang, Chunyan Xu, Wenqiu Tian, Fei Xie, Bin Yue, Palanivel Velmurugan. Therapeutic Effect of Bicyclol Coupled with Aspirin Nanopreparation on Liver Function Damage Caused by Epstein‐Barr Virus Infection in Children. Journal of Nanomaterials 2022; 2022(1) doi: 10.1155/2022/9609398
|
| 29 |
Andrea Boccatonda, Lorenza Del Cane, Lara Marola, Damiano D’Ardes, Gianfranco Lessiani, Nicoletta di Gregorio, Claudio Ferri, Francesco Cipollone, Carla Serra, Francesca Santilli, Fabio Piscaglia. Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Life 2024; 14(4): 473 doi: 10.3390/life14040473
|
| 30 |
Xun Qiu, Fengqiang Gao, Kai Wang, Zhensheng Zhang, Chuxiao Shao, Xiao Xu. Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?. iLIVER 2022; 1(1): 55 doi: 10.1016/j.iliver.2022.03.003
|
| 31 |
Zulfqarul Haq, Syed Mudasir Ahmad, Ishrat Bashir, Mashooq Ahmad Dar, Afnan Saleem, Azmat Alam Khan, Mohammad Iqbal Yatoo, Shabir Mir, Ankur Rastogi, Mohd Isfaqul Hussain, Riaz A. Shah, Basharat Bhat. Pathogenesis-Related Gene Expression in Response to Trachyspermum ammi Supplementation Along With Probiotics in Chicken Salmonellosis and Insights in Drug Therapeutics. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.866614
|
| 32 |
Likun Liu, Jinhui Du, Haiqing Fan, Yue Yu, Yilin Luo, Fang Gu, Hui Yu, Xin Liao. Blueberry anthocyanins improve liver fibrosis by regulating NCOA4 ubiquitination through TRIM7 to affect ferroptosis of hepatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(4): G426 doi: 10.1152/ajpgi.00227.2023
|